Enovis Corp
Research Enovis Corp (ENOV) on Bullrun: market cap USD 1.48B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerENOV
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.48B
- Financial periodQ2 2026
- RevenueUSD 589.15M
- Net income-USD 8.76M
- Free cash flow-USD 28.85M
- Gross margin62.0%
Valuation Snapshot
latest market cap is USD 1.48B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.25B | -USD 1.18B | USD 19.92M | 59.8% | -20.75 | USD 36.39M | USD 1.30B | USD 1.49B |
| FY2024 | USD 2.11B | -USD 825.49M | -USD 67.21M | 56.0% | -14.93 | USD 48.17M | USD 1.33B | USD 2.56B |
| FY2023 | USD 1.71B | -USD 33.26M | USD 12.77M | 58.0% | -0.61 | USD 36.19M | USD 466.16M | USD 3.42B |
| FY2022 | USD 1.56B | -USD 13.29M | -USD 161.31M | 55.6% | -0.25 | USD 24.30M | USD 259.28M | USD 3.45B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.48B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.52B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.45B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 3.06B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.90B | 54.6 | n/a | n/a |
| 2021 | 2021-12-31 | USD 4.12B | 21.7 | n/a | n/a |
About Enovis Corp
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Related stock research
Other Healthcare stocks
ESTABLISHMENT LABS HLDGS (3E0)
Senseonics Holdings Inc. (6L60)
Abbott Laboratories (ABT)
Adagio Medical Holdings Inc (ADGM)
Aethlon Medical Inc (AEMD)
AdaptHealth Corp (AHCO)
Alamar Biosciences, Inc. (ALMR)
Allurion Technologies Inc (ALUR)
Autonomix Medical Inc (AMIX)
Artivion Inc (AORT)
AOTI Inc (AOTI)
Apyx Medical Corp (APYX)
Frequently asked questions
What is Enovis Corp's market cap?
Enovis Corp's market capitalization is USD 1.48B.
What does Enovis Corp do?
Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.